Top news from MedWatch this week

Monday
Malaria breakthrough hope rekindled by pandemic research after 30 years of stagnation
Four drugs recommended for approval by CHMP at April meeting
Tuesday
Huge executive reshuffle at Saniona – firm to stop US activities
Lundbeck VP joins board of migraine firm
Wednesday
Demant to divest hearing implant division to Cochlear
Demant CEO won’t rule out dismissals following divestment of implant division
Demant’s hearing implant division struggled with recalls and pandemic pressure
Cochlear relieves Demant of loss-making implant division
Thursday
Y-mabs CEO resigns with immediate effect
Friday
One day a month, Genmab employees are free to do as they please
Novo Nordisk upgrades full-year guidance
Novo Nordisk aims to submit hemophilia drug for approval this year
Novo Nordisk terminates program on innovative insulin
Novo Nordisk unveils Wegovy sales
Pent-up demand for hearing aids continues to boost sales in US